4//SEC Filing
KELLEY SCOTT 4
Accession 0001209191-21-002566
CIK 0001419600other
Filed
Jan 6, 7:00 PM ET
Accepted
Jan 7, 5:58 PM ET
Size
5.5 KB
Accession
0001209191-21-002566
Insider Transaction Report
Form 4
KELLEY SCOTT
Chief Medical Officer
Transactions
- Sale
Common Stock
2021-01-05$11.13/sh−6,829$76,007→ 113,549 total
Footnotes (3)
- [F1]Sale of shares of common stock to cover tax withholding obligations associated with the vesting of restricted stock unit awards granted to the Reporting Person on February 1, 2018, March 1, 2019, and March 2, 2020.
- [F2]The weighted average sale price for the transaction reported was $11.13. The shares were sold at a range of prices between $11.12 and $11.55. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- [F3]Includes 668 shares of Common Stock that were acquired by the Reporting Person on December 21, 2020, at $9.77 per share pursuant to the Issuer's Employee Stock Purchase Plan.
Documents
Issuer
Flexion Therapeutics Inc
CIK 0001419600
Entity typeother
Related Parties
1- filerCIK 0001222950
Filing Metadata
- Form type
- 4
- Filed
- Jan 6, 7:00 PM ET
- Accepted
- Jan 7, 5:58 PM ET
- Size
- 5.5 KB